You are here

Pfizer sues Johnson & Johnson over anti-competitive tactics

It claims J&J acted to squash its cheaper version of powerful rheumatoid arthritis drug


A LEGAL brawl between two of the world's largest drug companies could shape the future of a nascent market of copycat drugs that are intended to bring down the cost of the most advanced and expensive medicines.

Pfizer filed a lawsuit on Wednesday against fellow...

Market voices on: